Introduction
Members of the subfamily Paramyxovirinae are enveloped negative-stranded RNA viruses ; several are important human pathogens, for example mumps virus, measles virus, and parainfluenza virus types 1-4. The Paramyxovirinae contains three genera, Paramyxovirus, Rubulavirus and Morbillivirus. Members of the genus Paramyxovirus and Rubulavirus have two kinds of projection on the viral envelope : one is a haemagglutinin-neuraminidase (HN) protein and has receptorbinding and receptor-destroying activities ; the other is the fusion (F) protein, whose proteolytic processing is a prerequisite for inducing membrane fusion. The paramyxovirus virions attach to the cell-surface receptors via the HN proteins, and the F proteins trigger envelope-cell fusion, enabling the viral nucleocapsid to penetrate into the cytoplasm. Interaction of HN-F-expressing cells with neighbouring cells is also required for syncytium formation. Syncytium formation and subsequent generalized cell fusion have been reported as potentially important mechanisms of virus-induced cytotoxic effects. Therefore, cell fusion of paramyxovirus-infected cells with neighbouring cells to form multinucleated syncytia contributes to the pathogenic effects of paramyxoviruses.
We previously reported that infection of L *#* cells by Newcastle disease virus (NDV) induced little cell fusion because of abortive replication and that the addition of anti-L *#* cell antiserum to the culture medium enhanced syncytium formation in NDV-infected L *#* cells (Nagai et al., 1981 ; Ito et al., 1987 b) . This finding suggested that factor(s) that are capable of regulating virus-mediated cell fusion are present on the surface of host cells. In addition, we have isolated monoclonal antibodies (MAbs) capable of enhancing cell fusion in NDV-infected HeLa cells (Ito et al., 1992) . These MAbs immunoprecipitated gp80 and gp135, which were detected on the surface of HeLa cells. Since these molecules appeared to regulate NDV-mediated cell fusion, gp80 and gp135 were designated as fusion regulatory protein (FRP)-1 and FRP-2, respectively (Ito et al., 1992) . Anti-(human) FRP-1 MAbs showed no effect on L *#* cells due to the absence crossreactivity with murine FRP-1. Furthermore, the addition of anti-FRP-1 MAb to NDV-infected L *#* cells expressing human FRP-1 led to giant polykaryocytes, but control antibody caused no cell fusion (Ohgimoto et al., 1995) , indicating that NDV-induced cell fusion is regulated by FRP-1 molecules.
Anti-FRP-1 antibodies also enhanced human immunodeficiency virus (HIV) gp160-mediated cell fusion (Ohta et al., 1994) . Anti-FRP-1 antibodies were found to induce homotypic cell aggregation and multinucleated giant cell formation of monocytes without any fusogen (Tabata et al., 1995) . We have recently found that FRP-1 is identical with the heavy chain subunit of 4F2\CD98 (Ohgimoto et al., 1995) . 4F2 is a 120 to 130 kDa disulfide-linked heterodimer, composed of an 80 to 90 kDa glycosylated heavy chain and a 35 to 40 kDa nonglycosylated light chain (Hashimoto et al., 1983 ; Haynes et al., 1981 ; Hemler et al., 1982 ; Ohgimoto et al., 1995) . It has been reported that 4F2\CD98 molecules have multiple functions, as an amino acid transporter (Wells et al., 1992) , Na + \Ca# + exchanger (Michalak et al., 1986 ; Wacholtz et al., 1992) and cell growth factor (Friedman et al., 1994 ; MacDonald et al., 1985 ; Spagnoll et al., 1991) . However, relationships between these functions and fusion regulatory activity remained unknown. Recently, we have found that some anti-FRP-1 MAbs showed inhibitory activity against FRP-1 systemmediated cell fusion, indicating that the FRP-1\CD98 molecule is capable of either activating or inhibiting cell fusion, depending on whether the stimulant is an activating or an inhibiting anti-FRP-1 MAb. Thus, FRP-1\CD98 is a multipotential molecule.
In the present study, to further clarify the role of FRP-1 molecules in virus-induced cell fusion, we tried to suppress the activity of FRP-1 by a dominant negative inhibitor. Paramyxovirus-induced cell fusion was found to be suppressed in HeLa cells stably expressing mutated FRP-1 proteins, indicating that the FRP-1 molecule is required for paramyxovirusinduced cell fusion.
Methods
Viruses and cells. The viruses used in this study were human parainfluenza virus type 2 (HPIV-2 ; Toshiba strain), simian virus 41 (SV41 ; Toshiba\Chanock strain), simian virus 5 (SV5 ; 21004-WR strain), mumps virus (Miyahara strain), NDV (Sato strain) and measles virus (Toyoshima strain). HeLa, Vero and L *#* cells were grown in Eagle's MEM (MEM) supplemented with 5 % foetal calf serum.
Virus titration. Infectivities of NDV and HPIV-2 were titrated on Vero cells and expressed as p.f.u.\ml .
Monoclonal antibodies.
MAbs directed against human FRP-1\CD98 (6-1-13 and 4-5-1) and against HPIV-2 were described previously (Ito et al., 1992 ; Tsurudome et al., 1989) . Anti-human FRP-1 MAbs showed no effect on L *#* cells due to absence of cross-reactivity with murine FRP-1.
Flow-cytometric analysis. For detection of intracytoplasmic antigen, the cells were fixed with 10 % paraformaldehyde in PBS for 15 min and permeabilized for 20 min with 0n05 % Triton X-100 in PBS. Fixed or unfixed cells were stained using the primary antibody for 1 h and then were reacted with the secondary antiserum conjugated with FITC.
Immunofluorescence-stained cells were analysed on a FACScan using Consort 30 software (Becton-Dickinson).
Enzyme-linked immunosorbent assay. ELISA was performed as described previously (Ohgimoto et al., 1995) , except that human FRP-1\4F2-expressing L *#* cells and peroxidase-conjugated goat anti-mouse immunoglobulin (diluted 1 : 2000 ; Cappel Laboratories) were used as the coating antigen and the secondary serum, respectively.
Isotopic labelling, radioimmunoprecipitation assay and SDS-PAGE. Isotopic labelling of HeLa cells, RIPA and SDS-PAGE were done as described previously .
Isotopic labelling of NDV-infected cells. Approximately 2i10' cells were infected with NDV at an input m.o.i. of 1 p.f.u. per cell. At 12 h post-infection (p.i.), the cells were depleted of methionine and then labelled with [$&S]methionine (40 mCi ; Amersham) for 12 h. The cultures were lysed with 1 ml of RIPA buffer (150 mM NaCl, 1 % sodium deoxycholate, 1 % Triton X-100, 0n1 % SDS, 10 mM Tris-HCl pH 7n4 and 100 KIU of aprotinin\ml). After centrifugation at 10 000 r.p.m. for 10 min, the resulting supernatants were kept at 4 mC until use.
Plasmid construction (i) Construction of the wild-type FRP-1 gene. A cDNA clone of the human FRP-1 gene was inserted into plasmid expression vector pcDL-SRα296 downstream of the SV40 early promoter and R-U5 sequence of the human T-lymphotropic virus type I LTR to obtain the plasmid pDS-FRP-1. pcDL-SRα296 was kindly donated by Y. Takebe (NIH, Japan).
(ii) Preparation of a construct encoding a chimeric mutated FRP-1/CD98 protein (FRP-1/HN) in which the cytoplasmic domain is replaced by the cytoplasmic domain of HPIV-2 haemagglutininneuraminidase. PCR was performed to amplify a cDNA fragment including the FRP-1 extracellular and transmembrane domains and partial 3h non-coding sequences from plasmid pSRα\FRP-1H using primers 5h GGATCCTGGGCACTGCTGCTGC 3h and 5h AAGCTTGGTAGTG-GGTCCATGT 3h, generating a BamHI site at the 5h end and a HindIII site at the 3h end (Quackenbush et al., 1987 ; Teixeira et al., 1987) . This cDNA fragment was dG-tailed and annealed with the plasmid pBluescript II SK(k), which had been digested with PstI, blunt-ended and dC-tailed, to give pBlu\FRP-1-extra. Similarly, the HPIV-2 HN cytoplasmic and partial 5h non-coding sequences were isolated by PCR from the HPIV-2 HN cDNA using primers 5h GAATTCAACATATAAT-TGTAAG 3h and 5h GGATCCTCGGAAAATGATTCTA 3h, creating an EcoRI site at the 5h end and a BamHI site at the 3h end (Kawano et al., 1990) . This HPIV-2 HN cytoplasmic cDNA fragment was also dGtailed and annealed with dC-tailed pBluescript II SK(k) to give pBlu\ HN-cyto. The cDNA fragment encoding the FRP-1 extracellular and transmembrane domain generated by digesting plasmid pBlu\FRP-1-extra with BamHI and HindIII was ligated to the HPIV-2 HN cytoplasmic cDNA fragment (pBlu\FRP-1-HN). The cDNA encoding the FRP-1 extracellular and transmembrane domain-HPIV-2 HN cytoplasmic domain chimeric protein was generated by digestion of pBlu\FRP- 2 2 4 n 6 2 2 6-1-13 2 2 6 n 3 2 2 HBJ127 2 2 3 n 6 2 2 38-2-2 2 2 2 2 18-1-2 2 2 2 2 1-HN with EcoRI and HindIII. The expression vector pcDL-SRα296, which contains the SV40 promoter, was digested with PstI, blunt-ended and dC-tailed. The cDNA fragment encoding the FRP-1 extracellular and transmembrane domain-HPIV-2 HN cytoplasmic domain chimeric protein was then blunt-ended, dG-tailed and annealed with dC-tailed pcDL-SRα296. The direction of the inserted cDNA was confirmed by nucleotide sequencing of the 5h and 3h ends. The pcDL-SRα296 derivative plasmid harbouring the cDNA encoding the FRP-1 extracellular and transmembrane domain-HPIV-2 HN cytoplasmic domain chimeric protein was designated pSRα\FRP-1-HN. FRP-1/CD98 and virus-induced fusion FRP-1/CD98 and virus-induced fusion for resistance to G418 (Geneticin ; Life Technologies). For establishment of L *#* and HeLa cell lines stably expressing mutated FRP-1 proteins, transfected cells were cultured in soft agar containing G418. To confirm expression of the proteins, FACS analysis or RT-PCR was performed.
Detection of FRP-1/HN mRNA by RT-PCR.
Each cellular mRNA was isolated from HeLa cells, and from L *#* or HeLa cell lines constitutively expressing FRP-1\HN proteins by using a commercial mRNA purification kit (QuickPrep, Pharmacia). HPIV-2 HN cDNA was synthesized using a first-strand cDNA synthesis kit (Pharmacia) with the downstream primer 5h GGATCCTCGGAAAATGATTCTA 3h, and then amplified for 30 cycles by PCR using the upstream primer 5h GAATTCAACATATAATTGTAAG 3h under the following conditions ; 94 mC for 1 min, 50 mC for 1 min and 72 mC for 30 s.
Fusion index.
To estimate the degree of cell fusion, cells were stained with Giemsa's solution, and then a minimum of 1000 nuclei or cells within multinucleated giant cells ( 3 nuclei\cell) were counted. The fusion index was calculated using the formula : fusion index( %) l total number of nuclei within giant cells\total number of nuclei countedi100.
Results

Mutated FRP-1/CD98 molecules lack fusion regulatory activity
First, in order to determine the functional domains on FRP-1, mutated FRP-1 molecules were constructed by molecular genetic technology. Since the cytoplasmic domains of many cellular receptors have been reported to play an important role in intracellular signal transduction, and cysteine is related to disulfide linkages and to conformational structure, the following two mutated FRP-1 molecules were constructed : (i) FRP-1\HN, in which the cytoplasmic domain was replaced with the cytoplasmic domain of HPIV-2 haemagglutininneuraminidase ; (ii) FRP-1\330 (serine), in which the cysteine at amino acid 330 in the extracytoplasmic domain was mutated to serine. These constructs were transfected into L *#* cells, and then L *#* cells constitutively expressing each mutated FRP-1 molecule were established. Expression of each mutated protein was analysed by FACS ( Fig. 1) and RIPA\SDS-PAGE (data not shown). We isolated several clones of L *#* -FRP-1\HN cells, but the expression level of FRP-1\HN was always lower that that of either FRP-1 or FRP-1\330 (serine). The FRP-1\330 (serine) mutated protein was capable of binding to the light chain of FRP-1 (data not shown). Subsequently, to test whether the mutated FRP-1 molecules were functional for fusion regulatory activity, L *#* cells constitutively expressing each mutated FRP-1 molecule were infected with NDV and incubated in the presence of anti-FRP-1 antibodies. The FRP-1\HN and FRP-1\330 (serine) mutated proteins were inactive in fusion induction by NDV together with an activating antibody directed against FRP-1 (Table 1) 
Establishment of HeLa-FRP-1/HN cells (HeLa cells constitutively expressing FRP-1/HN)
In the next experiment, we established several HeLa cell lines constitutively expressing FRP-1\HN (designated HeLa-FRP-1\HN cells). To ascertain expression of the mutated FRP-1 molecule cells were analysed by RT-PCR using primers specific to the mutated FRP-1 mRNA. As shown in Fig. 1 , mRNA of mutated FRP-1 was detected in both L *#* -FRP-1\HN and HeLa-FRP-1\HN (lines 2-C, 2-E, X-1 and X-2) cells, but not in parent HeLa and HeLa-pkan-2 cells. When FRP-1 (intact FRP-1 and mutated FRP-1) expression in these cells was analysed by FACS using an anti-FRP-1 MAb (4-5-6), neither overexpression nor lower expression of FRP-1 was detected (data not shown). (Fig. 2, panel I, A) . When these NDV-infected cells were incubated in the presence of the anti-FRP-1 antibody, cell fusion was distinct in the presence of the anti-FRP-1 antibody at about 11 h p.i. ; almost all nuclei were found in multinucleated giant cells by about 17 h p.i. (Fig.  2, panel I, B) . On the other hand, when NDV-infected HeLa-FRP-1\HN cells were incubated for 17 h in the presence or absence of the anti-FRP-1 antibody, no cell fusion was detected (Table 2 ; Fig. 2, panel I, A, B) . In addition, HPIV-2-induced cell fusion was suppressed\delayed in HeLa-FRP-1\HN cells compared with parent HeLa and HeLa-pkan-2 cells (Table 3 ; Fig. 2, panel I, C, panel II) . Finally, we isolated six HeLa cell lines expressing the mutated FRP-1\HN, all of which showed resistance to multinucleated giant cell formation caused by NDV and HPIV-2 (data not shown). In addition, we isolated ten other HeLa cell lines expressing pkan-2 alone, and NDV and HPIV-2 induced cell fusion in these cells to the same extent as in parent HeLa cells. Thus, the FRP-1\HN mutated protein functions as a dominant negative inhibitor of fusion regulatory activity. Furthermore, we isolated four clones of HeLa cells constitutively expressing another mutated FRP-1, FRP-1\330 (serine) ; NDV-and HPIV-2-induced cell fusion was suppressed in these cells also (data not shown).
Induction of giant cell formation in NDV-infected
Multinucleated giant cell formation in HeLa-FRP-1/HN cells infected with other paramyxoviruses
We investigated multinucleated giant cell formation in HeLa-FRP-1\HN cells infected with other paramyxoviruses including SV5, SV41 and mumps virus. Parent HeLa, HeLapkan-2 and HeLa-FRP-1\HN cells were infected with paramyxovirus at an m.o.i. of approximately 1, and then the cultures were incubated in MEM-5 % foetal calf serum. After 24-30 h, the cells were fixed, stained with Giemsa's stain solution, and observed with a microscope. As shown in Table  3 and Fig. 2 
NDV and HPIV-2 replication in HeLa-FRP-1/HN cells
To investigate whether suppression of cell fusion in HeLa-FRP-1\HN cells was due to low level replication of NDV or HPIV-2, the virus-infected cell cultures were examined for virus growth. As shown in Fig. 3 , production of infective viruses, synthesis of virus-specific polypeptides and expression of virus glycoproteins on the cell surface were not suppressed in HeLa-FRP-1\HN cells, indicating that suppression of cell fusion in such cells is not due to suppression of virus penetration or reduced virus replication.
Discussion
In this study, to determine which domains\sites on FRP-1 molecules were important for fusion regulation, two cDNAs encoding mutated FRP-1 molecules were constructed and L *#* cell lines constitutively expressing each mutated FRP-1 were established. The cytoplasmic domain and a cysteine at amino acid 330 in the FRP-1 molecule were shown to be related to fusion regulatory function. An anti-FRP-1 MAb induced rapid tyrosine phosphorylation of multiple cellular proteins in U937-2 cells and pp130 tyrosine phosphorylation appears to be a specific and early signal transmitted after interaction of FRP-1 with a specific antibody (unpublished data). Analysis of whether or not pp130 tyrosine phosphorylation can be detected in L *#* cells expressing mutated FRP-1 molecules is in progress in our laboratory. Furthermore, the fusion regulatory activity of endogenous FRP-1 was found to be suppressed in HeLa cells expressing FRP-1\HN mutated protein (HeLa-FRP-1\HN cells) . Therefore, the FRP-1\HN mutated protein functions as a dominant negative inhibitor of fusion regulation. However, the mechanism by which it does so remains unknown. One of the possibilities is that mutated FRP-1 binds to the light chain of FRP-1, resulting in dysfunction of intact FRP-1.
When HeLa-FRP-1\HN cells were infected with different rubulavirus strains, virus-induced polykaryocyte formation was suppressed\delayed, though virus yield, synthesis of virus-specific polypeptides and expression of viral glycoproteins (HN and F proteins) were not suppressed. These findings indicate that the intact FRP-1 molecule is required for rubulavirus-induced cell-cell fusion. We have recently found that FRP-1 is identical to the heavy chain subunit of 4F2\CD98 (Hashimoto et al., 1983 ; Haynes et al., 1981 ; Hemler et al., 1982 ; Ohgimoto et al., 1995) . It has been reported that 4F2\CD98 molecules have multiple functions, but the relationships between these known functions and fusion regulatory activity remain unresolved. Up to the present, the molecular mechanism by which rubulavirus-induced cell-fusion is suppressed in cells expressing mutated FRP-1 molecules remains unsolved.
